DOI: 10.1016/s0169-409x(02)00026-1. PEGylated antibodies and antibody fragments for improved therapy: a review

PEGylated antibodies and antibody fragments for improved therapy: a review

10.1016/s0169-409x(02)00026-1

Crossref journal-article

Elsevier BV

Advanced Drug Delivery Reviews (78)

Bibliography

Chapman, A. P. (2002). PEGylated antibodies and antibody fragments for improved therapy: a review. Advanced Drug Delivery Reviews, 54(4), 531â545.

Authors 1

Andrew P. Chapman (first)

References 38 Referenced 472

{'key': '10.1016/S0169-409X(02)00026-1_BIB1', 'first-page': '110', 'article-title': 'Recombinant antibodies for the diagnosis and therapy of human disease', 'volume': '2', 'author': 'King', 'year': '1999', 'journal-title': 'Curr. Opin. Drug Discov. Dev.'} / Curr. Opin. Drug Discov. Dev. / Recombinant antibodies for the diagnosis and therapy of human disease by King (1999)
10.1038/78720 / Nat. Biotechnol. / Biopharmaceutical benchmarks by Walsh (2000)
10.1038/nbt0698-535 / Nat. Biotechnol. / Human antibodies by design by Vaughan (1998)
10.1021/bc00032a002 / Bioconjug. Chem. / Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates by Zalipsky (1995)
10.1016/S0925-5710(98)00039-5 / Int. J. Haematol. / PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques by Francis (1998)
{'key': '10.1016/S0169-409X(02)00026-1_BIB6', 'series-title': 'Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications', 'first-page': '1', 'article-title': 'Introduction to biotechnical and biomedical applications of poly(ethylene glycol)', 'author': 'Harris', 'year': '1992'} / Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications / Introduction to biotechnical and biomedical applications of poly(ethylene glycol) by Harris (1992)
10.1016/0076-6879(94)28037-1 / Methods Enzymol. / Use of poly(ethylene glycol)-modified antibody in cell extraction by Karr (1994)
10.1016/0076-6879(94)28039-8 / Methods Enzymol. / Bioextraction of low abundance cells by affinity partitioning by Delgado (1994)
10.1016/0022-1759(92)90139-K / J. Immunol. Methods / Biological activities of polyethylene-glycol immunoglobulin conjugates by Cunningham-Rundles (1992)
10.1615/CritRevTherDrugCarrierSyst.v17.i2.20 / Crit. Rev. Ther. Drug Carrier Syst. / Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review by Greenwald (2000)
10.1080/07366578508081960 / JMS—Rev. Macromol. Chem. Phys. / Laboratory synthesis of polyethylene glycol derivatives by Harris (1985)
10.1021/bc960059o / Bioconjug. Chem. / PEG thiazolidine-2-thione, a novel reagent for facile protein modification: conjugation of bovine hemoglobin by Greenwald (1996)
10.1021/bc9600224 / Bioconjug. Chem. / Preparation and characterisation of poly(ethylene glycol) vinyl sulfone by Morpurgo (1996)
{'key': '10.1016/S0169-409X(02)00026-1_BIB14', 'series-title': 'Applications and Engineering of Monoclonal Antibodies', 'first-page': '1', 'article-title': 'Preparation, structure and function of monoclonal antibodies', 'author': 'King', 'year': '1998'} / Applications and Engineering of Monoclonal Antibodies / Preparation, structure and function of monoclonal antibodies by King (1998)
10.1016/0167-4838(84)90268-1 / Biochim. Biophys. Acta / Physiochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G by Suzuki (1984)
10.1111/j.1349-7006.1991.tb01769.x / Jpn. J. Cancer Res. / Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol by Takashina (1991)
{'key': '10.1016/S0169-409X(02)00026-1_BIB17', 'first-page': '4310', 'article-title': 'Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy', 'volume': '51', 'author': 'Kitamura', 'year': '1991', 'journal-title': 'Cancer Res.'} / Cancer Res. / Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy by Kitamura (1991)
10.1016/0006-291X(90)90839-F / Biochem. Biophys. Res. Commun. / Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization by Kitamura (1990)
10.1038/bjc.1994.459 / Br. J. Cancer / The potential for enhanced tumour localisation by poly(ethylene glycol) modification of an anti-CEA antibody by Pedley (1994)
10.1038/bjc.1996.32 / Br. J. Cancer / Enhanced tumour specificity of an anti-carcinoembryonic antigen Fab′ by poly(ethylene glycol) (PEG) modification by Delgado (1996)
{'key': '10.1016/S0169-409X(02)00026-1_BIB21', 'first-page': '235', 'article-title': 'Improved tumour targeting of di-Fab’ fragments modified with polyethylene glycol', 'volume': '4', 'author': 'Casey', 'year': '2000', 'journal-title': 'Tumor Target.'} / Tumor Target. / Improved tumour targeting of di-Fab’ fragments modified with polyethylene glycol by Casey (2000)
10.1038/11717 / Nat. Biotechnol. / Therapeutic antibody fragments with prolonged in vivo half-lives by Chapman (1999)
10.1021/bc990076o / Bioconjug. Chem. / Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: A comparison of conjugation chemistries and compounds by Lee (1999)
10.1016/S0378-5173(99)00458-5 / Int. J. Pharm. / Modulating pharmacokinetics of an anti-interleukin-8 F(ab′)2 by amine-specific PEGylation with preserved bioactivity by Koumenis (2000)
10.1016/0022-1759(88)90439-5 / J. Immunol. Methods / Polymer modification of antibody to eliminate immune complex and Fc binding by Anderson (1988)
10.4049/jimmunol.143.8.2595 / J. Immunol. / Studies of aglycosylated chimeric mouse-human IgG by Tao (1989)
10.1038/332738a0 / Nature / The binding site for C1q on IgG by Duncan (1988)
10.1038/332563a0 / Nature / Localization of the binding site for the human high affinity Fc receptor on IgG by Duncan (1988)
10.1016/0161-5890(93)90097-U / Mol. Immunol. / Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody by Co (1993)
{'key': '10.1016/S0169-409X(02)00026-1_BIB30', 'first-page': '55', 'article-title': 'Rapid clearance of aglycosyl recombinant chimeric B72.3(γ4) antibody in athymic mice bearing human colorectal xenografts', 'volume': '3', 'author': 'Rhind', 'year': '1990', 'journal-title': 'Antibod. Immunoconj. Radiopharm.'} / Antibod. Immunoconj. Radiopharm. / Rapid clearance of aglycosyl recombinant chimeric B72.3(γ4) antibody in athymic mice bearing human colorectal xenografts by Rhind (1990)
{'key': '10.1016/S0169-409X(02)00026-1_BIB31', 'first-page': '6176', 'article-title': 'Improved tumor targeting with chemically cross-linked recombinant antibody fragments', 'volume': '54', 'author': 'King', 'year': '1994', 'journal-title': 'Cancer Res.'} / Cancer Res. / Improved tumor targeting with chemically cross-linked recombinant antibody fragments by King (1994)
10.1002/1097-0215(20000801)87:3<382::AID-IJC12>3.0.CO;2-P / Int. J. Cancer / Pharmacokinetics and microdistribution of polyethylene glycol-mediated humanized A33 antibody targeting colon cancer xenografts by Deckert (2000)
10.1016/0165-2478(87)90070-8 / Immunol. Lett. / Tolerogenic polyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins by Wilkinson (1987)
10.1038/bjc.1993.288 / Br. J. Cancer / Comparative radioimmunotherapy using intact or F(ab′)2 fragments of 131I-anti-CEA antibody in a colonic xenograft model by Pedley (1993)
10.1038/bjc.1994.338 / Br. J. Cancer / Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab′)2 antibodies by Lane (1994)
10.1007/BF03259352 / Clin. Immunother. / Pharmacokinetics of monoclonal antibodies by Pedley (1996)
10.1016/S0168-3659(99)00248-5 / J. Controlled Release / Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review by Maeda (2000)
P.A. Vasey, S.B. Kaye, R. Morrison, C. Tweleves, P. Wilson, R. Duncan, A.H. Thomson, L.S. Murray, T.E. Hilditch, T. Murray, S. Burtles, D. Fraier, E. Frigerio, J. Cassidy, Phase I clinical and pharmacokinetic study of PK1 (HPMA co-polymer doxorubicin): First member of a new class of chemotherapeutic agents—drug–polymer conjugates. Clin. Cancer Res. 5 (199) 83–94.

Dates

Type	When
Created	22 years, 10 months ago (Oct. 10, 2002, 10:36 p.m.)
Deposited	2 years, 4 months ago (April 18, 2023, 12:20 p.m.)
Indexed	1 day ago (Sept. 2, 2025, 6:35 a.m.)
Issued	23 years, 3 months ago (June 1, 2002)
Published	23 years, 3 months ago (June 1, 2002)
Published Print	23 years, 3 months ago (June 1, 2002)

Funders 0

None

BibTeX

@article{Chapman_2002, title={PEGylated antibodies and antibody fragments for improved therapy: a review}, volume={54}, ISSN={0169-409X}, url={http://dx.doi.org/10.1016/s0169-409x(02)00026-1}, DOI={10.1016/s0169-409x(02)00026-1}, number={4}, journal={Advanced Drug Delivery Reviews}, publisher={Elsevier BV}, author={Chapman, Andrew P.}, year={2002}, month=jun, pages={531–545} }

JSON

{
  "indexed": {
    "date-parts": [
      [
        2025,
        9,
        2
      ]
    ],
    "date-time": "2025-09-02T10:35:12Z",
    "timestamp": 1756809312852
  },
  "reference-count": 38,
  "publisher": "Elsevier BV",
  "issue": "4",
  "license": [
    {
      "start": {
        "date-parts": [
          [
            2002,
            6,
            1
          ]
        ],
        "date-time": "2002-06-01T00:00:00Z",
        "timestamp": 1022889600000
      },
      "content-version": "tdm",
      "delay-in-days": 0,
      "URL": "https://www.elsevier.com/tdm/userlicense/1.0/"
    }
  ],
  "content-domain": {
    "domain": [],
    "crossmark-restriction": false
  },
  "published-print": {
    "date-parts": [
      [
        2002,
        6
      ]
    ]
  },
  "DOI": "10.1016/s0169-409x(02)00026-1",
  "type": "journal-article",
  "created": {
    "date-parts": [
      [
        2002,
        10,
        11
      ]
    ],
    "date-time": "2002-10-11T02:36:45Z",
    "timestamp": 1034303805000
  },
  "page": "531-545",
  "source": "Crossref",
  "is-referenced-by-count": 472,
  "title": "PEGylated antibodies and antibody fragments for improved therapy: a review",
  "prefix": "10.1016",
  "volume": "54",
  "author": [
    {
      "given": "Andrew P.",
      "family": "Chapman",
      "sequence": "first",
      "affiliation": []
    }
  ],
  "member": "78",
  "reference": [
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB1",
      "first-page": "110",
      "article-title": "Recombinant antibodies for the diagnosis and therapy of human disease",
      "volume": "2",
      "author": "King",
      "year": "1999",
      "journal-title": "Curr. Opin. Drug Discov. Dev."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB2",
      "doi-asserted-by": "crossref",
      "first-page": "831",
      "DOI": "10.1038/78720",
      "article-title": "Biopharmaceutical benchmarks",
      "volume": "18",
      "author": "Walsh",
      "year": "2000",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB3",
      "doi-asserted-by": "crossref",
      "first-page": "535",
      "DOI": "10.1038/nbt0698-535",
      "article-title": "Human antibodies by design",
      "volume": "16",
      "author": "Vaughan",
      "year": "1998",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB4",
      "doi-asserted-by": "crossref",
      "first-page": "150",
      "DOI": "10.1021/bc00032a002",
      "article-title": "Functionalized poly(ethylene glycol) for preparation of biologically relevant conjugates",
      "volume": "6",
      "author": "Zalipsky",
      "year": "1995",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB5",
      "doi-asserted-by": "crossref",
      "first-page": "1",
      "DOI": "10.1016/S0925-5710(98)00039-5",
      "article-title": "PEGylation of cytokines and other therapeutic proteins and peptides: the importance of biological optimisation of coupling techniques",
      "volume": "68",
      "author": "Francis",
      "year": "1998",
      "journal-title": "Int. J. Haematol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB6",
      "series-title": "Poly(ethylene Glycol) Chemistry: Biotechnical and Biomedical Applications",
      "first-page": "1",
      "article-title": "Introduction to biotechnical and biomedical applications of poly(ethylene glycol)",
      "author": "Harris",
      "year": "1992"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB7",
      "doi-asserted-by": "crossref",
      "first-page": "377",
      "DOI": "10.1016/0076-6879(94)28037-1",
      "article-title": "Use of poly(ethylene glycol)-modified antibody in cell extraction",
      "volume": "228",
      "author": "Karr",
      "year": "1994",
      "journal-title": "Methods Enzymol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB8",
      "doi-asserted-by": "crossref",
      "first-page": "395",
      "DOI": "10.1016/0076-6879(94)28039-8",
      "article-title": "Bioextraction of low abundance cells by affinity partitioning",
      "volume": "228",
      "author": "Delgado",
      "year": "1994",
      "journal-title": "Methods Enzymol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB9",
      "doi-asserted-by": "crossref",
      "first-page": "177",
      "DOI": "10.1016/0022-1759(92)90139-K",
      "article-title": "Biological activities of polyethylene-glycol immunoglobulin conjugates",
      "volume": "152",
      "author": "Cunningham-Rundles",
      "year": "1992",
      "journal-title": "J. Immunol. Methods"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB10",
      "doi-asserted-by": "crossref",
      "first-page": "101",
      "DOI": "10.1615/CritRevTherDrugCarrierSyst.v17.i2.20",
      "article-title": "Poly(ethylene glycol) conjugated drugs and prodrugs: a comprehensive review",
      "volume": "17",
      "author": "Greenwald",
      "year": "2000",
      "journal-title": "Crit. Rev. Ther. Drug Carrier Syst."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB11",
      "doi-asserted-by": "crossref",
      "first-page": "325",
      "DOI": "10.1080/07366578508081960",
      "article-title": "Laboratory synthesis of polyethylene glycol derivatives",
      "volume": "C25",
      "author": "Harris",
      "year": "1985",
      "journal-title": "JMS\u2014Rev. Macromol. Chem. Phys."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB12",
      "doi-asserted-by": "crossref",
      "first-page": "638",
      "DOI": "10.1021/bc960059o",
      "article-title": "PEG thiazolidine-2-thione, a novel reagent for facile protein modification: conjugation of bovine hemoglobin",
      "volume": "7",
      "author": "Greenwald",
      "year": "1996",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB13",
      "doi-asserted-by": "crossref",
      "first-page": "363",
      "DOI": "10.1021/bc9600224",
      "article-title": "Preparation and characterisation of poly(ethylene glycol) vinyl sulfone",
      "volume": "7",
      "author": "Morpurgo",
      "year": "1996",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB14",
      "series-title": "Applications and Engineering of Monoclonal Antibodies",
      "first-page": "1",
      "article-title": "Preparation, structure and function of monoclonal antibodies",
      "author": "King",
      "year": "1998"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB15",
      "doi-asserted-by": "crossref",
      "first-page": "248",
      "DOI": "10.1016/0167-4838(84)90268-1",
      "article-title": "Physiochemical and biological properties of poly(ethylene glycol)-coupled immunoglobulin G",
      "volume": "788",
      "author": "Suzuki",
      "year": "1984",
      "journal-title": "Biochim. Biophys. Acta"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB16",
      "doi-asserted-by": "crossref",
      "first-page": "1145",
      "DOI": "10.1111/j.1349-7006.1991.tb01769.x",
      "article-title": "Comparative pharmacokinetic properties of murine monoclonal antibody A7 modified with neocarzinostatin, dextran and polyethylene glycol",
      "volume": "82",
      "author": "Takashina",
      "year": "1991",
      "journal-title": "Jpn. J. Cancer Res."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB17",
      "first-page": "4310",
      "article-title": "Chemical engineering of the monoclonal antibody A7 by polyethylene glycol for targeting cancer chemotherapy",
      "volume": "51",
      "author": "Kitamura",
      "year": "1991",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB18",
      "doi-asserted-by": "crossref",
      "first-page": "1387",
      "DOI": "10.1016/0006-291X(90)90839-F",
      "article-title": "Polyethylene glycol modification of the monoclonal antibody A7 enhances its tumor localization",
      "volume": "171",
      "author": "Kitamura",
      "year": "1990",
      "journal-title": "Biochem. Biophys. Res. Commun."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB19",
      "doi-asserted-by": "crossref",
      "first-page": "1126",
      "DOI": "10.1038/bjc.1994.459",
      "article-title": "The potential for enhanced tumour localisation by poly(ethylene glycol) modification of an anti-CEA antibody",
      "volume": "70",
      "author": "Pedley",
      "year": "1994",
      "journal-title": "Br. J. Cancer"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB20",
      "doi-asserted-by": "crossref",
      "first-page": "175",
      "DOI": "10.1038/bjc.1996.32",
      "article-title": "Enhanced tumour specificity of an anti-carcinoembryonic antigen Fab\u2032 by poly(ethylene glycol) (PEG) modification",
      "volume": "73",
      "author": "Delgado",
      "year": "1996",
      "journal-title": "Br. J. Cancer"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB21",
      "first-page": "235",
      "article-title": "Improved tumour targeting of di-Fab\u2019 fragments modified with polyethylene glycol",
      "volume": "4",
      "author": "Casey",
      "year": "2000",
      "journal-title": "Tumor Target."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB22",
      "doi-asserted-by": "crossref",
      "first-page": "780",
      "DOI": "10.1038/11717",
      "article-title": "Therapeutic antibody fragments with prolonged in vivo half-lives",
      "volume": "17",
      "author": "Chapman",
      "year": "1999",
      "journal-title": "Nat. Biotechnol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB23",
      "doi-asserted-by": "crossref",
      "first-page": "973",
      "DOI": "10.1021/bc990076o",
      "article-title": "Prolonged circulating lives of single-chain Fv proteins conjugated with polyethylene glycol: A comparison of conjugation chemistries and compounds",
      "volume": "10",
      "author": "Lee",
      "year": "1999",
      "journal-title": "Bioconjug. Chem."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB24",
      "doi-asserted-by": "crossref",
      "first-page": "83",
      "DOI": "10.1016/S0378-5173(99)00458-5",
      "article-title": "Modulating pharmacokinetics of an anti-interleukin-8 F(ab\u2032)2 by amine-specific PEGylation with preserved bioactivity",
      "volume": "198",
      "author": "Koumenis",
      "year": "2000",
      "journal-title": "Int. J. Pharm."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB25",
      "doi-asserted-by": "crossref",
      "first-page": "37",
      "DOI": "10.1016/0022-1759(88)90439-5",
      "article-title": "Polymer modification of antibody to eliminate immune complex and Fc binding",
      "volume": "109",
      "author": "Anderson",
      "year": "1988",
      "journal-title": "J. Immunol. Methods"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB26",
      "doi-asserted-by": "crossref",
      "first-page": "2595",
      "DOI": "10.4049/jimmunol.143.8.2595",
      "article-title": "Studies of aglycosylated chimeric mouse-human IgG",
      "volume": "143",
      "author": "Tao",
      "year": "1989",
      "journal-title": "J. Immunol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB27",
      "doi-asserted-by": "crossref",
      "first-page": "738",
      "DOI": "10.1038/332738a0",
      "article-title": "The binding site for C1q on IgG",
      "volume": "332",
      "author": "Duncan",
      "year": "1988",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB28",
      "doi-asserted-by": "crossref",
      "first-page": "563",
      "DOI": "10.1038/332563a0",
      "article-title": "Localization of the binding site for the human high affinity Fc receptor on IgG",
      "volume": "332",
      "author": "Duncan",
      "year": "1988",
      "journal-title": "Nature"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB29",
      "doi-asserted-by": "crossref",
      "first-page": "1361",
      "DOI": "10.1016/0161-5890(93)90097-U",
      "article-title": "Genetically engineered deglycosylation of the variable domain increases the affinity of an anti-CD33 monoclonal antibody",
      "volume": "30",
      "author": "Co",
      "year": "1993",
      "journal-title": "Mol. Immunol."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB30",
      "first-page": "55",
      "article-title": "Rapid clearance of aglycosyl recombinant chimeric B72.3(\u03b34) antibody in athymic mice bearing human colorectal xenografts",
      "volume": "3",
      "author": "Rhind",
      "year": "1990",
      "journal-title": "Antibod. Immunoconj. Radiopharm."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB31",
      "first-page": "6176",
      "article-title": "Improved tumor targeting with chemically cross-linked recombinant antibody fragments",
      "volume": "54",
      "author": "King",
      "year": "1994",
      "journal-title": "Cancer Res."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB32",
      "doi-asserted-by": "crossref",
      "first-page": "382",
      "DOI": "10.1002/1097-0215(20000801)87:3<382::AID-IJC12>3.0.CO;2-P",
      "article-title": "Pharmacokinetics and microdistribution of polyethylene glycol-mediated humanized A33 antibody targeting colon cancer xenografts",
      "volume": "87",
      "author": "Deckert",
      "year": "2000",
      "journal-title": "Int. J. Cancer"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB33",
      "doi-asserted-by": "crossref",
      "first-page": "17",
      "DOI": "10.1016/0165-2478(87)90070-8",
      "article-title": "Tolerogenic polyethylene glycol derivatives of xenogeneic monoclonal immunoglobulins",
      "volume": "15",
      "author": "Wilkinson",
      "year": "1987",
      "journal-title": "Immunol. Lett."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB34",
      "doi-asserted-by": "crossref",
      "first-page": "69",
      "DOI": "10.1038/bjc.1993.288",
      "article-title": "Comparative radioimmunotherapy using intact or F(ab\u2032)2 fragments of 131I-anti-CEA antibody in a colonic xenograft model",
      "volume": "68",
      "author": "Pedley",
      "year": "1993",
      "journal-title": "Br. J. Cancer"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB35",
      "doi-asserted-by": "crossref",
      "first-page": "521",
      "DOI": "10.1038/bjc.1994.338",
      "article-title": "Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab\u2032)2 antibodies",
      "volume": "70",
      "author": "Lane",
      "year": "1994",
      "journal-title": "Br. J. Cancer"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB36",
      "doi-asserted-by": "crossref",
      "first-page": "54",
      "DOI": "10.1007/BF03259352",
      "article-title": "Pharmacokinetics of monoclonal antibodies",
      "volume": "6",
      "author": "Pedley",
      "year": "1996",
      "journal-title": "Clin. Immunother."
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB37",
      "doi-asserted-by": "crossref",
      "first-page": "271",
      "DOI": "10.1016/S0168-3659(99)00248-5",
      "article-title": "Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review",
      "volume": "65",
      "author": "Maeda",
      "year": "2000",
      "journal-title": "J. Controlled Release"
    },
    {
      "key": "10.1016/S0169-409X(02)00026-1_BIB38",
      "unstructured": "P.A. Vasey, S.B. Kaye, R. Morrison, C. Tweleves, P. Wilson, R. Duncan, A.H. Thomson, L.S. Murray, T.E. Hilditch, T. Murray, S. Burtles, D. Fraier, E. Frigerio, J. Cassidy, Phase I clinical and pharmacokinetic study of PK1 (HPMA co-polymer doxorubicin): First member of a new class of chemotherapeutic agents\u2014drug\u2013polymer conjugates. Clin. Cancer Res. 5 (199) 83\u201394."
    }
  ],
  "container-title": "Advanced Drug Delivery Reviews",
  "original-title": [],
  "language": "en",
  "link": [
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0169409X02000261?httpAccept=text/xml",
      "content-type": "text/xml",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "https://api.elsevier.com/content/article/PII:S0169409X02000261?httpAccept=text/plain",
      "content-type": "text/plain",
      "content-version": "vor",
      "intended-application": "text-mining"
    }
  ],
  "deposited": {
    "date-parts": [
      [
        2023,
        4,
        18
      ]
    ],
    "date-time": "2023-04-18T16:20:20Z",
    "timestamp": 1681834820000
  },
  "score": 1,
  "resource": {
    "primary": {
      "URL": "https://linkinghub.elsevier.com/retrieve/pii/S0169409X02000261"
    }
  },
  "subtitle": [],
  "short-title": [],
  "issued": {
    "date-parts": [
      [
        2002,
        6
      ]
    ]
  },
  "references-count": 38,
  "journal-issue": {
    "issue": "4",
    "published-print": {
      "date-parts": [
        [
          2002,
          6
        ]
      ]
    }
  },
  "alternative-id": [
    "S0169409X02000261"
  ],
  "URL": "http://dx.doi.org/10.1016/S0169-409X(02)00026-1",
  "relation": {},
  "ISSN": [
    "0169-409X"
  ],
  "subject": [],
  "container-title-short": "Advanced Drug Delivery Reviews",
  "published": {
    "date-parts": [
      [
        2002,
        6
      ]
    ]
  }
}